QualityStocksNewsBreaks Archives - Page 474 of 1387

TuesdayDec 21, 2021 12:31 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Announces New Agriculture Advisor, Interview with CEO

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has appointed an agriculture advisor; University of Guelph professor and researcher Dr. Claudia Wagner-Riddle will fill the role. In the announcement, the company noted that agriculture is the first sector FuelPositive plans to help transition away from the current seriously problematic and exploitative traditional ammonia supply chain. Wagner-Riddle is uniquely qualified to lead the company’s efforts in this focus. She leads a research program utilizing the measurement of greenhouse gas emissions to determine the carbon footprint of food, feed and fuel…

TuesdayDec 21, 2021 12:05 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) CEO Featured in Latest EDGE Podcast Interview

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) CEO and president Lorne Rapkin was profiled on the EDGE Podcast, hosted by Brandon C. White. During the interview, Rapkin discussed his background, noting that he was an entrepreneur at an early age, building and running companies even when he was in school. He also talked about PlantX and its efforts to become a trusted and convenient destination for people living plant-based lives. EDGE Podcast features a series of interviews focused on providing the business owner's playbook about the inner game of building a successful business and giving listeners the edge to become…

TuesdayDec 21, 2021 11:49 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming January Events

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in two premier events: the 11th annual LifeSci Partners Annual Corporate Access Event and the H.C. Wainwright Bioconnect Conference. Cybin CEO Doug Drysdale will participate in both upcoming virtual investor events. At the LifeSci Partners event, scheduled for Jan. 5–7, 2021, Drysdale will be involved in a panel discussion titled “Psychedelics: More Than Just a Trip.” The panel is slated for Wednesday, Jan. 5, at 10 a.m. ET. At the H.C. Wainwright Bioconnect Conference, Drysdale willparticipate in a fireside chat, which is scheduled…

TuesdayDec 21, 2021 11:13 am

QualityStocksNewsBreaks – Genenta Science S.p.A. (NASDAQ: GNTA) Announces Completion of $36 Million IPO

Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for solid tumors, including the lead product candidate, Temferon(TM), has closed on its upsized initial public offering. The offering was comprised of 2.4 million American Depositary Shares, or ADSs, with each one representing one ordinary share, offered at a public price of $11.50 per share. In addition, Genenta also sold 720,114 ordinary shares reserved for subscription; those were purchased by existing shareholders for $11.50 per share. According to the announcement, gross proceeds from the IPO reached approximately $36 million before typical deductions.…

MondayDec 20, 2021 2:17 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Standing Distinct in Advancing Psychedelic Medicine

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) recently released financials and a business update for the third quarter ending Sept. 30, 2021. During this reporting period, the company filed three patent applications; successfully synthesized a novel psilocin analogue with improved pharmaceutical properties; launched Mindleap 2.0, an updated version of its proprietary virtual health platform; and completed its spin-out transaction of ALT House Cannabis Inc. “The highlight of this quarter was the five-year research agreement Mydecine Innovations entered with Johns Hopkins University School of Medicine… The agreement gives the company’s medical and scientific research teams the resources needed to explore things…

MondayDec 20, 2021 1:57 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Advancing Core Research, Commercial Production Programs, Identifying Pipeline Expansion Opportunities

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently provided an update sharing significant milestones reached in 2021 for both of its operating arms, MINDCURE Research and MINDCURE Technology. MINDCURE Research offered several updates, including important milestones in its synthetic ibogaine manufacturing; the company is currently on schedule to provide Good Laboratory Practice (“GLP”) ibogaine to its research partners by the second quarter of 2022. In addition, a pre-clinical update from MINDCURE confirms that it intends to send ibogaine material to its pre-clinical research partner. Initially, the product will be…

MondayDec 20, 2021 1:27 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Working to Make Fan Pass a Household Name

Friendable’s (OTC: FDBL) Fan Pass platform has seen massive growth since its launch in July 2020, with thousands of established and independent artists signing up in the last 12 months. The platform has reached multiple significant milestones this year, including the launch of an updated version, the publication of new mobile applications in both the Apple Store and Google Play, and the release of an Artist Pro offering that brings new features and benefits for members. A recent article reads, “The company goes into 2022 with a commitment to continue expanding its reach and offering to artists and fans alike.…

MondayDec 20, 2021 12:17 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ranks in List of Top 101 Canadian F&B Startups and Companies

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has been named one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. The ranking recognizes the company’s leadership position within both the food & beverage and cannabis product categories. Companies listed in the rankings include cutting-edge startups and established brands alike, but each company is known for innovation within their sector, exceptional growth and societal impact. BevCanna was within the group of selected companies that exhibited exceptional performance. In addition, BVNNF was also included within…

MondayDec 20, 2021 11:59 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Leading Mechanical, Plant Engineering Firm

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is partnering with Dürr, one of the world's leading mechanical and plant engineering firms. Durr brings extensive expertise in automation and digitalization to the partnership, which is designed to focus on MULN’s EV manufacturing footprint. According to the agreement, Dürr, which has extensive expertise in automation and digitalization, will support Mullen’s Advanced Manufacturing and Engineering Center (“AMEC”) with full integration for vehicle assembly and complete paint shop technologies; the engineering center is located in Tunica, Mississippi. "Dürr is a leading international manufacturing systems and technology provider for the automotive industry,”…

MondayDec 20, 2021 11:39 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces General Meeting Voting, Publication of Key Article on CBN as Possible Glaucoma Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, held its general meeting on Dec. 17, 2021, and approved the election of all director nominees. Those elected will hold office until the next annual shareholder meeting or until their successors are elected or appointed. The company also noted that all of the matters outlined for consideration and approval in InMed’s notice of meeting and management information circular were approved. In addition, the company announced that an article discussing cannabinol (“CBN”) as a potential treatment option for glaucoma has been published in a peer-reviewed journal.…

Site Search

Company Search

Category: QualityStocksNewsBreaks